Veeru Kasivisvanathan

Nov 4, 2024 | nature.com | Jonathan Olivier |Pawel Rajwa |Riccardo Campi |Alessandro Veccia |Alessandro Marquis |Veeru Kasivisvanathan | +4 more

AbstractTo investigate the detection and predictors of prostate cancer (PCA) and clinically significant prostate cancer (csPCA) in patients with positive multiparametric MRI (mpMRI) followed by a negative MRI – guided target biopsy (TB) and systematic biopsy (SB). This retrospective multicenter study included 694 patients from 10 tertiary referral centers with an initial positive mpMRI (PI-RADS ≥ 3) and negative results on both MRI-TB and SB.

Oct 12, 2023 | inkl.com | Alexander Ng |Veeru Kasivisvanathan |Hayley Luxton

Changing how MRIs are carried out could triple the number of scans used to detect prostate cancer, potentially making diagnosis quicker and more effective, researchers have said. MRI scans are standard for men suspected of having the disease and can allow doctors to rule out cancer without the need for a tissue biopsy, but demand has risen sharply. The scans are currently carried out in three phases, with imaging done without contrast in the first instance.